| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 20/09/2024 | 09:00 to 10:00 | AUDITORIUM 12 |
ATHEROSCLEROSIS/ CARDIOVASCULAR RISK FACTORS/ CARDIOVASCULAR PREVENTION CARDIAC Special department activities - DA - Obesity and cardiovascular risk (206) |
09:28 to 09:40 | Reducing cardiovascular risk in people living with obesity: what works and what doesn't. What is the lesson from SELECT? | SPEAKER |
| 20/09/2024 | 12:10 to 13:40 | AUDITORIUM 02 |
Atividade patrocinada Satellite Symposium - NOVO NORDISK Satellite Symposium - Wegovy: A new era in obesity treatment and cardiovascular protection (311) |
SPEAKER | ||
| 20/09/2024 | 15:50 to 16:50 | AUDITORIUM 12 |
ATHEROSCLEROSIS/ CARDIOVASCULAR RISK FACTORS/ CARDIOVASCULAR PREVENTION CARDIAC Update - What's new in the management of residual inflammatory risk? (1) |
16:18 to 16:30 | Anti-inflammatory therapy in reducing residual risk: are we ready yet? | SPEAKER |
| 20/09/2024 | 17:30 to 18:30 | AUDITORIUM 01 |
HEART FAILURE/ CARDIOMYOPATHY/ TRANSPLANTATION, ATHEROSCLEROSIS/ CARDIOVASCULAR RISK FACTORS/ CARDIOVASCULAR PREVENTION CARDIAC, EPIDEMIOLOGY AND HEALTH POLICIES / GLOBAL HEALTH International Symposium - HFpEF and the cardiometabolic epidemic (45) |
17:46 to 17:58 | Impact of obesity | SPEAKER |